Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Part 7: CUTV News Radio Welcomes Back Regenerative Medicine Pioneer Dr. Joy Kong

  • Broadcast in Medicine
CUTV News Radio

CUTV News Radio

×  

Follow This Show

If you liked this show, you should follow CUTV News Radio.
h:362063
s:11481281
archived

LOS ANGELES, CA - Dr. Joy Kong is a woman who tackles the impossible time and again. It began in her youth, with her efforts to study medicine and migrate to the United States. It was her sheer determination that helped her overcome numerous obstacles. In later years, she triumphed again, by treating tough conditions and seeing measurable improvement in patients. She is achieving the impossible again, with the introduction of products of such strength and purity never before available. She is also making another stride in her field, by helping other doctors to comprehend and use regenerative medicine therapies and enrich their practices.

Dr. Kong is also introducing listeners to her memoir, Tiger of Beijing, which will be out in October. Dr. Kong’s book begins with her personal journey and determination to get out of China and study in the US. The book goes on to tell a universal story about sticking to one’s goals, rising above difficult situations, and finding your purpose.

Dr. Kong got her medical degree from UCLA School of Medicine in California and worked in various settings such as Emergency Care, Veteran’s Affairs clinics, alcohol & drug rehabilitation centers, mental health clinics and county hospitals. She has been helping people in dire situations for a long time. Today she is the CEO of Chara Biologics, which sources, develops and provides exciting integrative therapies and personal care products. She also runs the Thea Center for Regenerative Medicine, is the president of American Academy of Integrative Cell Therapy.

Dr. Kong says “Cell therapy is one of the most exciting fields of medicine.”

For more information about Dr. Kong and her work visit https:///charabiologics.com

Comments